April 14, 2005 -- The U.S. Food and Drug Administration (FDA) has approved mometasone furoate inhalation powder for the maintenance treatment of asthma as prophylactic therapy in patients aged 12 ...

has won approval of a combined therapy for brittle bone disease. The Food and Drug Administration approved the once-weekly Fosamax Plus D, an osteoporosis treatment containing the drug Fosamax and ...

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

Merck & Company's Fosamax Plus D (alendronate sodium/cholecalciferol), a single once-weekly tablet containing 70 mg Fosamax (alendronate sodium) and 2800 IU vitamin D3, representing seven days worth ...

Two of the biggest makers of generic drugs, Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals Inc., said Wednesday they will immediately begin selling generic Fosamax, which is made by ...

SAN FRANCISCO (MarketWatch) -- Merck & Co. on Friday said the Food and Drug Administration has approved Fosamax Plus D, its weekly osteoporosis tablet containing vitamin D. Back To Top ...